Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ramkissoon, Shakti"'
Autor:
Mankan AK; Fortrea Inc, Durham, NC., Shankar A; Department of Radiation Oncology, Dr BR Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Delhi, India., Limaye S; Sir HN Reliance Foundation Hospital, Mumbai, India., Ajaikumar BS; HCG Group of Hospitals, Bangalore, India., Nachane P; Fortrea Inc, Durham, NC., Singh N; PostGraduate Institute of Medical Education and Research, Chandigarh, India., Dawkhar S; Fortrea Inc, Durham, NC., Batra U; Rajiv Gandhi Cancer Centre, New Delhi, India., Bhosekar A; Fortrea Inc, Durham, NC., Ganguly S; Tata Medical Centre, Kolkata, India., Gawli P; Fortrea Inc, Durham, NC., Debnath K; Wockhardt Ltd, Mumbai, India., Padalalu V; Fortrea Inc, Durham, NC., Reddy P; Labcorp Oncology, Durham, NC., Sundaramoorthy S; Fortrea Inc, Durham, NC., Naveen KK; Fortrea Inc, Durham, NC., Bondarde S; Apex Wellness Hospital, Nashik, India., Kumar P; Fortrea Inc, Durham, NC., Davis S; Indian Society for Clinical Research, Mumbai, India., Ramkissoon SH; Labcorp Oncology, Durham, NC., Chacko RT; Christian Medical College, Vellore, India., Vidal L; Fortrea Inc, Durham, NC., Chico I; Fortrea Inc, Durham, NC., Hegedus A; Fortrea Inc, Durham, NC., Gupta S; Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Saini KS; Fortrea Inc, Durham, NC.; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2024 Jun; Vol. 10, pp. e2300405.
Autor:
Huang RSP; Foundation Medicine, Inc., Morrisville, NC., Xiao J; Foundation Medicine, Inc., Morrisville, NC., Pavlick DC; Foundation Medicine, Inc., Cambridge, MA., Guo C; Foundation Medicine, Inc., Cambridge, MA., Yang L; Foundation Medicine, Inc., Cambridge, MA., Jin DX; Foundation Medicine, Inc., Cambridge, MA., Fendler B; Foundation Medicine, Inc., Cambridge, MA., Severson E; Foundation Medicine, Inc., Morrisville, NC., Killian JK; Foundation Medicine, Inc., Cambridge, MA., Hiemenz M; Foundation Medicine, Inc., Cambridge, MA., Duncan D; Foundation Medicine, Inc., Morrisville, NC., Lin DI; Foundation Medicine, Inc., Cambridge, MA., Dennis L; Foundation Medicine, Inc., Cambridge, MA., Aiyer A; Foundation Medicine, Inc., Cambridge, MA., Gjoerup O; Foundation Medicine, Inc., Cambridge, MA., Oxnard G; Foundation Medicine, Inc., Cambridge, MA., Venstrom J; Foundation Medicine, Inc., Cambridge, MA., Elvin J; Foundation Medicine, Inc., Cambridge, MA., Ramkissoon SH; Foundation Medicine, Inc., Morrisville, NC.; Wake Forest Comprehensive Cancer Center, and Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC., Ross JS; Foundation Medicine, Inc., Cambridge, MA.; Department of Pathology, State University of New York (SUNY) Upstate Medical University, Syracuse, NY.
Publikováno v:
Clinical chemistry [Clin Chem] 2021 Nov 01; Vol. 67 (11), pp. 1554-1566.
Autor:
Huang RSP; Foundation Medicine Inc, Cambridge, Massachusetts, USA rhuang@foundationmedicine.com., Decker B; Foundation Medicine Inc, Cambridge, Massachusetts, USA., Murugesan K; Foundation Medicine Inc, Cambridge, Massachusetts, USA., Hiemenz M; Foundation Medicine Inc, Cambridge, Massachusetts, USA., Mata DA; Foundation Medicine Inc, Cambridge, Massachusetts, USA., Li G; Foundation Medicine Inc, Cambridge, Massachusetts, USA., Creeden J; Foundation Medicine Inc, Cambridge, Massachusetts, USA., Ramkissoon SH; Foundation Medicine Inc, Cambridge, Massachusetts, USA.; Wake Forest Comprehensive Cancer Center, Winston-Salem, North Carolina, USA.; Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Ross JS; Foundation Medicine Inc, Cambridge, Massachusetts, USA.; Department of Pathology, State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jun; Vol. 9 (6).
Autor:
Huang RSP; Foundation Medicine, Inc., Morrisville, NC, USA. rhuang@foundationmedicine.com., Haberberger J; Foundation Medicine, Inc., Morrisville, NC, USA., Severson E; Foundation Medicine, Inc., Morrisville, NC, USA., Duncan DL; Foundation Medicine, Inc., Morrisville, NC, USA., Hemmerich A; Foundation Medicine, Inc., Morrisville, NC, USA., Edgerly C; Foundation Medicine, Inc., Morrisville, NC, USA., Ferguson NL; Foundation Medicine, Inc., Morrisville, NC, USA., Williams E; Foundation Medicine, Inc., Cambridge, MA, USA., Elvin J; Foundation Medicine, Inc., Cambridge, MA, USA., Vergilio JA; Foundation Medicine, Inc., Cambridge, MA, USA., Killian JK; Foundation Medicine, Inc., Cambridge, MA, USA., Lin DI; Foundation Medicine, Inc., Cambridge, MA, USA., Tse J; Foundation Medicine, Inc., Cambridge, MA, USA., Hiemenz M; Foundation Medicine, Inc., Cambridge, MA, USA., Owens C; Foundation Medicine, Inc., Morrisville, NC, USA., Danziger N; Foundation Medicine, Inc., Cambridge, MA, USA., Hegde PS; Foundation Medicine, Inc., Cambridge, MA, USA., Venstrom J; Foundation Medicine, Inc., Cambridge, MA, USA., Alexander B; Foundation Medicine, Inc., Cambridge, MA, USA., Ross JS; Foundation Medicine, Inc., Cambridge, MA, USA.; Department of Pathology, State University of New York (SUNY) Upstate Medical University, Syracuse, NY, USA., Ramkissoon SH; Foundation Medicine, Inc., Morrisville, NC, USA.; Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2021 Feb; Vol. 34 (2), pp. 252-263. Date of Electronic Publication: 2020 Sep 03.
Autor:
Severson EA; Foundation Medicine, Inc., Morrisville, NC., Riedlinger GM; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ., Connelly CF; Foundation Medicine, Inc., Cambridge, MA., Vergilio JA; Foundation Medicine, Inc., Cambridge, MA., Goldfinger M; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Department of Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ., Ramkissoon S; Foundation Medicine, Inc., Morrisville, NC.; Department of Pathology, Wake Forest Baptist Health and Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC; and., Frampton GM; Foundation Medicine, Inc., Cambridge, MA., Ross JS; Foundation Medicine, Inc., Cambridge, MA., Fratella-Calabrese A; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Gay L; Foundation Medicine, Inc., Cambridge, MA., Ali S; Foundation Medicine, Inc., Cambridge, MA., Miller V; Foundation Medicine, Inc., Cambridge, MA., Elvin J; Foundation Medicine, Inc., Cambridge, MA., Hadigol M; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Hirshfield KM; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Department of Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ., Rodriguez-Rodriguez L; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Department of Obstetrics and Gynecology, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ., Ganesan S; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Department of Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ., Khiabanian H; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ.; Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ.
Publikováno v:
Blood [Blood] 2018 May 31; Vol. 131 (22), pp. 2501-2505. Date of Electronic Publication: 2018 Apr 20.
Autor:
Hartmaier RJ; Foundation Medicine, Cambridge, Massachusetts. rhartmaier@foundationmedicine.com dlipson@foundationmedicine.com., Albacker LA; Foundation Medicine, Cambridge, Massachusetts., Chmielecki J; Foundation Medicine, Cambridge, Massachusetts., Bailey M; Foundation Medicine, Cambridge, Massachusetts., He J; Foundation Medicine, Cambridge, Massachusetts., Goldberg ME; Foundation Medicine, Cambridge, Massachusetts., Ramkissoon S; Foundation Medicine, Cambridge, Massachusetts., Suh J; Foundation Medicine, Cambridge, Massachusetts., Elvin JA; Foundation Medicine, Cambridge, Massachusetts., Chiacchia S; Foundation Medicine, Cambridge, Massachusetts., Frampton GM; Foundation Medicine, Cambridge, Massachusetts., Ross JS; Foundation Medicine, Cambridge, Massachusetts.; Albany Medical College, Albany, New York., Miller V; Foundation Medicine, Cambridge, Massachusetts., Stephens PJ; Foundation Medicine, Cambridge, Massachusetts., Lipson D; Foundation Medicine, Cambridge, Massachusetts. rhartmaier@foundationmedicine.com dlipson@foundationmedicine.com.
Publikováno v:
Cancer research [Cancer Res] 2017 May 01; Vol. 77 (9), pp. 2464-2475. Date of Electronic Publication: 2017 Feb 24.
Autor:
Chmielecki J; Foundation Medicine, Cambridge, Massachusetts., Bailey M; Foundation Medicine, Cambridge, Massachusetts., He J; Foundation Medicine, Cambridge, Massachusetts., Elvin J; Foundation Medicine, Cambridge, Massachusetts., Vergilio JA; Foundation Medicine, Cambridge, Massachusetts., Ramkissoon S; Foundation Medicine, Cambridge, Massachusetts., Suh J; Foundation Medicine, Cambridge, Massachusetts., Frampton GM; Foundation Medicine, Cambridge, Massachusetts., Sun JX; Foundation Medicine, Cambridge, Massachusetts., Morley S; Foundation Medicine, Cambridge, Massachusetts., Spritz D; Foundation Medicine, Cambridge, Massachusetts., Ali S; Foundation Medicine, Cambridge, Massachusetts., Gay L; Foundation Medicine, Cambridge, Massachusetts., Erlich RL; Foundation Medicine, Cambridge, Massachusetts., Ross JS; Foundation Medicine, Cambridge, Massachusetts.; Albany Medical College, Albany, New York., Buxhaku J; Foundation Medicine, Cambridge, Massachusetts., Davies H; Foundation Medicine, Cambridge, Massachusetts., Faso V; Foundation Medicine, Cambridge, Massachusetts., Germain A; Foundation Medicine, Cambridge, Massachusetts., Glanville B; Foundation Medicine, Cambridge, Massachusetts., Miller VA; Foundation Medicine, Cambridge, Massachusetts., Stephens PJ; Foundation Medicine, Cambridge, Massachusetts., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.; Pediatrics, Harvard Medical School, Boston, Massachusetts., Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Meshinchi S; Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, Washington., Pugh TJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Shern JF; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Lipson D; Foundation Medicine, Cambridge, Massachusetts. dlipson@foundationmedicine.com.
Publikováno v:
Cancer research [Cancer Res] 2017 Jan 15; Vol. 77 (2), pp. 509-519. Date of Electronic Publication: 2017 Jan 09.
Autor:
Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Do K; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Early Drug Discovery Center., Shivdasani P; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Cerami E; Department of Biostatistics and Computational Biology, and., Dubuc AM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kuo FC; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Garcia EP; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Jia Y; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Davineni P; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Abo RP; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cancer Genome Discovery, DFCI, Boston, Massachusetts, USA., Pugh TJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Ontario, Canada., van Hummelen P; Department of Biostatistics and Computational Biology, and., Thorner AR; Center for Cancer Genome Discovery, DFCI, Boston, Massachusetts, USA., Ducar M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cancer Genome Discovery, DFCI, Boston, Massachusetts, USA., Berger AH; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Nishino M; Department of Radiology, DFCI and Brigham and Women's Hospital, Boston, Massachusetts, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Church A; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA., Harris M; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA., Ritterhouse LL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Campbell JD; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rojas-Rudilla V; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Ligon AH; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Ramkissoon S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Early Drug Discovery Center., Matulonis U; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Oxnard GR; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Chao R; Mirati Therapeutics, San Diego, California., Tassell V; Mirati Therapeutics, San Diego, California., Christensen J; Mirati Therapeutics, San Diego, California., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cancer Genome Discovery, DFCI, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.; Lank Center for Genitourinary Oncology and., Kantoff PW; Lank Center for Genitourinary Oncology and., Kwiatkowski DJ; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Johnson BE; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Meyerson M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cancer Genome Discovery, DFCI, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Garraway LA; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.; Center for Cancer Precision Medicine, DFCI, Boston, Massachusetts, USA., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Early Drug Discovery Center., Rollins BJ; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lindeman NI; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., MacConaill LE; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cancer Genome Discovery, DFCI, Boston, Massachusetts, USA.
Publikováno v:
JCI insight [JCI Insight] 2016 Nov 17; Vol. 1 (19), pp. e87062. Date of Electronic Publication: 2016 Nov 17.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Williams, Erik A., Santagata, Sandro, Wakimoto, Hiroaki, Shankar, Ganesh M., Barker, Fred G., Sharaf, Radwa, Reddy, Abhinav, Spear, Phoebe, Alexander, Brian M., Ross, Jeffrey S., Brastianos, Priscilla K., Cahill, Daniel P., Ramkissoon, Shakti H., Juratli, Tareq A.
Publikováno v:
Acta Neuropathologica Communications
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-10 (2020)
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-10 (2020)
Background Genomic studies of high-grade/progressive meningiomas have reported a heterogeneous mutation spectrum, identifying few recurrently mutated genes. Most studies have been underpowered to detect genomic subclasses of aggressive meningiomas du